For COVID-19 vaccine updates, please review our information guide. For patient eligibility and scheduling availability, please visit

The Cantley lab employs a wide range of techniques in its investigation of cancer metabolism and phosphoinositide signaling. From genetically engineered mouse model systems and human cancer cell lines to metabolomic, transcriptomic and proteomic analyses, to the biochemical characterization of enzymes, we use a variety of tools and an interdisciplinary approach to paint a more complete picture of cancer and develop therapies based on novel enzyme targets and other promising new approaches. The Cantley lab is based in New York City at the Sandra and Edward Meyer Cancer Center of the Weill Cornell Medical College and NewYork-Presbyterian Hospital. 

"If you’re not often wrong, you’re not at the frontier. If you’re not willing to go out on a limb and throw out ideas, then you’re not pushing the envelope."

- Dr. Lewis C. Cantley

The Cantley lab team

The Cantley lab welcomes a diverse set of talents and fosters an interdisciplinary approach in its attempts to translate fundamental scientific discoveries into clinical innovations.

The Cantley lab research

The Cantley lab's mission is to investigate the molecular underpinnings of cancer, and devise new treatments that combine lab and clinical innovations to directly benefit patients.